Navigation Links
Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry
Date:6/29/2009

SHANGHAI, June 29 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China announced today that Dr. Tong Xu has been appointed Vice President of Process Chemistry Services.

Prior to joining Sundia, Dr. Xu worked at La Jolla Pharmaceutical Company, an R&D based biotech company in San Diego, USA for 12 years. At La Jolla Pharmaceutical Company, Dr. Xu rose through the ranks from Research Scientist, to Manager, Senior Manager, and Associate Director of Process Development. Through this career path, he accumulated extensive experience in developing and managing process chemistry programs. His accomplishments include directing process development effort of Riquent(R) at clinical phase III and pre-commercialization stage.

"I am very pleased to welcome Dr. Xu to join Sundia. He is not only an outstanding scientist and research fellow, but also an experienced business manager," said Dr. Xiaochuan Wang, Chairman and CEO of Sundia. "Dr. Xu led the effort in his previous employment to search, select, negotiate and qualify CRO service providers in GLP and cGMP production of raw materials, starting materials, and API intermediates. This experience is very valuable for his new role to lead process chemistry CRO services at Sundia."

Dr. Xu received his bachelor's degree in Chemistry from Nankai University, and his Ph.D. degree in Organic Chemistry from the University of Michigan in USA. He also obtained an MBA with focus on finance and entrepreneurship from the Anderson School of Management at UCLA in USA.

About Sundia: Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China, to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide, ranging from early hit screening, biological service, lead optimization, DMPK, candidate preclinical development, formulation development, API manufacture, and regulatory submission. For more information, please visit http://www.sundia.com .


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
2. Sundias Animal Facility Passed Client and Government Inspection
3. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
4. Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
5. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
6. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
7. Novavax Appoints Stanley Erck to Board of Directors
8. Qforma Appoints Four Executives in Sales and Field Operations
9. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
10. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
11. Oncothyreon appoints Scott Peterson as Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) ... December 31, 2015. --> --> ... net loss of $29.3 million, or $0.34 loss per share, compared ... share for the same period in 2014. For the year ended ... million, or $1.05 loss per share, as compared to a net ...
(Date:2/11/2016)... and GERMANTOWN, Maryland , ... Frankfurt Prime Standard: QIA) today announced the introduction of ... gene expression profiling, expanding QIAGEN,s portfolio of Sample to ... researchers to select from over 20,000 human genes and ... between genes, cellular phenotypes and disease processes. --> ...
(Date:2/11/2016)... ATLANTA , Feb. 11, 2016  Spectra BioPharma ... Organization (CSO) that provides biopharma companies the experience, ... implement and deploy outsourced sales teams. Created in ... team addresses both the strategic and tactical needs ... innovative sales solutions through both personal and non-personal ...
(Date:2/11/2016)... (PRWEB) , ... February 11, ... ... business-to-business publication dedicated to delivering cutting-edge information focused on the development and ... Sciences to become a premier sponsor of the 2016 BioProcess International Awards ...
Breaking Biology Technology:
(Date:2/3/2016)... Feb. 3, 2016 ... of the "Emotion Detection and Recognition ... and Others), Software Tools (Facial Expression, Voice ... Users,and Regions - Global forecast to 2020" ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the ...
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
Breaking Biology News(10 mins):